Hepion Pharmaceuticals, Inc CTRVW

CTRVW OTC
CTRVW
Hepion Pharmaceuticals, Inc OTC
 
No trades
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E

CTRVW Chart

Trade CTRVW with trusted brokers on TradingView Open account

Profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate CRV431, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Edison, NJ.